A Viewpoint on the interplay between social, climate, and health challenges in Latin America and the Caribbean, in the context of SDGs 3, 10, and 13, highlighting the need to address these challenges with adaption and mitigation policies that prioritise people's health and wellbeing.
A Viewpoint in support of SDGs 3, 13, and 17, proposing a range of strategies for developing a 'public health playbook', to counter the 'corporate playbook' used by powerful commercial actors to protect their business interests at the expense of population health and wellbeing, including numerous health-harming and planet-harming industries, such as tobacco, alcohol, gambling, pharmaceuticals, ultraprocessed foods and beverages, firearms and weapons, automobiles, social media and technology, oil and gas, and chemicals.
A Comment on dementia and Alzheimer's disease costs, in the context of SDG 3, focusing specifically on the costs of care in Europe. Dementia is a syndrome characterized by progressive cognitive and functional impairment, most commonly caused by Alzheimer's disease and other neurodegenerative and cerebrovascular disorders. Costs of care increase dramatically with progressing disease severity, and increasing dementia prevalence due to ageing populations is raising concerns about the sustainability of future costs of dementia care. A new study shows that social welfare systems in Europe cover most of the direct costs of dementia, however they do not protect families and households against the burden of informal care. Meier and colleagues1 set out to calculate the economic costs of dementia in 11 European countries, by combining microdata from a population-based survey with estimates of dementia prevalence. Data for Austria, Belgium, Czechia, Denmark, Estonia, France, Germany, Italy, Slovenia, Spain, and Sweden was obtained from six waves of the Survey of Health, Ageing, and Retirement in Europe (SHARE). The survey captured out-of-pocket expenditures for health and social care as well as unpaid informal care. Costs attributable to dementia were estimated using linear regression, controlling for comorbidities and demographic factors. Finally, costs were combined with prevalence estimates to calculate the annual cost of dementia by country.
Discussion of the addition of glycemic index values to a Venezuelan food composition database with the aim of providing a useful resource for research and clinical settings in the region.
Background: Epidemiological studies have reported the associations between nitrogen dioxide (NO2) and pediatric asthma incidence, but unable to ascertain indoor NO2 sources.
Background: Hepatitis B virus (HBV) infection is a serious global health problem and China has the largest disease burden.
Elsevier, The Lancet Gastroenterology and Hepatology, Volume 7, July 2022
graphical abstract from Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission
Hepatitis C has increased in women of childbearing age and has important implications in women who become pregnant and their infants. The effect that hepatitis C has on pregnancy outcomes was evaluated as well as the rate of hepatitis C transmission to infants in a large database with linked mother-infant records. It was found that active hepatitis C during pregnancy increased the risk of pregnancy complications. Also identified were very low rates of testing of infants born to mothers with hepatitis C but found higher rates of hepatitis C transmission to infants in mothers with higher virus levels.
An Article on the global prevalence, mortality, and disability-adjusted life-years of hepatitis B, in the context of SDG 3, focusing specifically on a comparison of estimates to WHO elimination targets.
Elsevier,

The Lancet Regional Health - Western Pacific, Volume 22, 2022, 100428

An Article on the burden of chronic hepatitis B and C infections in Japan, in the context of SDG 3, highlighting the need for improved screening strategies for hepatitis C virus and development of new therapies leading to a functional cure for hepatitis B virus.

Pages